SHELL ASSET MANAGEMENT CO - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$772
-22.6%
24,421
-0.2%
0.03%
-17.9%
Q2 2023$998
+1484.1%
24,476
+1346.6%
0.04%
+1200.0%
Q1 2023$63
+6.8%
1,692
-0.4%
0.00%0.0%
Q4 2022$59
-99.9%
1,698
-16.8%
0.00%
-25.0%
Q3 2022$114,000
-14.3%
2,042
-20.7%
0.00%0.0%
Q2 2022$133,000
-28.9%
2,576
+0.2%
0.00%0.0%
Q1 2022$187,000
-46.4%
2,572
-12.9%
0.00%
-42.9%
Q4 2021$349,000
-11.4%
2,952
+0.6%
0.01%
-22.2%
Q3 2021$394,0002,9350.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders